Related Experiment Video
Updated: Jul 20, 2026

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Published on: July 28, 2012
[Intravesical treatment of non-muscle-invasive bladder cancer]
Henning Bahlburg1, Joachim Noldus1, Florian Roghmann2
1Klinik für Urologie und Neuro-Urologie, Marien Hospital Herne, Universitätsklinikum der Ruhr-Universität Bochum, Hölkeskampring 40, 44625, Herne, Deutschland.
Abstract:
Depending on the risk status, the treatment options for non-muscle-invasive bladder cancer (NMIBC) can include a bladder-preserving strategy with intravesical instillation treatment or early radical cystectomy. Established intravesical treatment options such as mitomycin C (MMC) or Bacillus Calmette-Guérin (BCG) are available to reduce the probability of progression and recurrence. This article classifies the intravesical treatment options in the therapeutic landscape of NMIBC and provides an overview of the indications and application regimens.
Related Concept Videos
Treatment Resistent Cancers
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi VI: Surgical Management

